Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Folic Acid and Trental in Chronic Kidney Disease
NCT05284656Phase 3Active, not recruiting
- Sponsor
- Al-Azhar University
- Start
- Jan 2022
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of pentoxifylline, folic acid in chronic kidney disease (CKD), sponsored by Al-Azhar University. Started Jan 2022; status: active, not recruiting.
02
Drugs
pentoxifyllinefolic acid
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT05284656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05284656.